<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Overexpression of decoy receptor (DcR) 3 protein, a recently discovered member of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor receptor superfamily, was examined in 40 esophagogastrectomy specimens containing areas of <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> (n = 27), low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 27), high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0002038'>carcinoma</z:mp> in situ (n = 22), and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (EAC; n = 28) with immunohistochemical analysis </plain></SENT>
<SENT sid="1" pm="."><plain>The results revealed significantly more overexpression of DcR3 in high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0002038'>carcinoma</z:mp> in situ and EAC than in benign esophageal mucosa (both P &lt; .0001), <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> (both P &lt; .001), and low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (P &lt; .01 and P = .033, respectively) </plain></SENT>
<SENT sid="2" pm="."><plain>Low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> also showed significant overexpression of DcR3 compared with benign esophagus (P &lt; .05) but not with <z:hpo ids='HP_0100580'>Barrett esophagus</z:hpo> (P &gt; .05) </plain></SENT>
<SENT sid="3" pm="."><plain>DcR3 overexpression seems to negatively correlate with the grade of EAC </plain></SENT>
<SENT sid="4" pm="."><plain>Our results suggest that overexpression of DcR3 protein might aid in the diagnosis of high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0002038'>carcinoma</z:mp> in situ and EAC and also might serve as a potential therapeutic target </plain></SENT>
</text></document>